Sign in to follow
Search Results

0 results for 'U.S. Food and Drug Administration'

You can use to get even better search results
March 29, 2024 | National Law Journal

What's in a Name? Group Urges Full 2nd Circuit to Scrap Rule Against Pseudonymity

The question could affect a recent influx of lawsuits against corporate diversity initiatives where conservative groups have sued on behalf of anonymous members, said employment lawyer Jason Schwartz.
7 minute read
March 29, 2024 | New Jersey Law Journal

Kirkland & Ellis Hired for Big Pharma Antitrust Suit

A 2020 verdict allowed Teva and other companies to produce generic versions of Vascepa. But Teva allegedly had to scale back its launch because of an inability to obtain the key ingredient, the suit said.
4 minute read
March 29, 2024 | The Legal Intelligencer

The Use of Ketamine for Trauma, Pain and Depression in Health Care

Ketamine, which was once used primarily as a recreational drug, is now being administered in clinics throughout the United States to treat patients suffering from trauma, pain and depression.
8 minute read
March 26, 2024 | National Law Journal

Anti-Abortion Group Faces Skeptical Supreme Court in FDA Challenge

"You need a person," Justice Elena Kagan said in questioning the group's legal footing to sue the Food and Drug Administration. "You need a person to be able to come in and meet the courts' regular standing requirements."
7 minute read
March 26, 2024 | Corporate Counsel

TV Legal Ads Proving Useful Radar for Next Big Mass Tort Categories

Tracking television legal ads that solicit plaintiffs for mass torts can give general counsel early warning of new trends and gauge the plaintiffs' bar's appetite in product litigation categories.
5 minute read
Law Journal Press | Digital Book Drug and Medical Device Product Liability Deskbook Authors: James M. Beck, Anthony Vale View this Book

View more book results for the query "U.S. Food and Drug Administration"

Regeneron Pharmaceuticals Inc. v. Novartis Pharma AG
Publication Date: 2024-03-26
Practice Area: Antitrust | Business Torts
Industry: Pharmaceuticals
Court: U.S. Court of Appeals for the Second Circuit
Judge: Circuit Judge Barrington D. Parker
Attorneys:
For plaintiff: For Plaintiff-Appellant: Joshua Halpern, Elizabeth S. Weiswasser, Eric S. Hochstadt, & Anish R. Desai, on the brief, Adam Banks, Weil, Gotshal & Manges LLP, New York, NY & Washington, D.C.
For defendant: For Defendants-Appellees Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corp.: Ian Simmons, Lisa Pensabene, Stephen J. McIntyre, & Melissa C. Cassel, on the brief, William Jay, O'Melveny & Myers LLP, Washington, D.C., New York, NY, Los Angeles, CA & San Francisco, CA. Benjamin T. Horton & Julianne M. Hartzell, on the brief, Marshall Gerstein & Borun LLP, Chicago, IL, for Defendant-Appellee Vetter Pharma International GmbH. Anisha S. Dasgupta & Joel Marcus, on the brief, Matthew M. Hoffman, Federal Trade Commission, Washington, D.C., and Jonathan S. Kanter, Daniel E. Haar, Nickolai G. Levin, & Andrew N. DeLaney, on the brief, United States Department of Justice, Antitrust Division, Washington, D.C., Amici Curiae in Support of Neither Party.
Case number: 22-0427-cv

Anti-VEGF Medications in Vials, Pre-Filled Syringes Compete in Different Product Markets

March 25, 2024 | The Legal Intelligencer

President Biden's New Strike Force on Unfair and Illegal Pricing

The strike force's launch is to continue the efforts of the president's Competition Council, which was established "to work across agencies to provide a coordinated response to overconcentration, monopolization, and unfair competition in or directly affecting the American economy."
5 minute read
March 25, 2024 | Supreme Court Brief

Abortion-Drug Hearing Headlines March Arguments

The justices this week will confront another major dispute dealing with abortion that could affect the reproductive health rights of millions of women around the country.
4 minute read
Deanda v. Becerra
Publication Date: 2024-03-25
Practice Area: Civil Appeals | Civil Rights | Class Actions
Industry:
Court: U.S. Court of Appeals for the Fifth Circuit
Judge: Circuit Judge Duncan
Attorneys:
For plaintiff:
For defendant:
Case number: 23-10159

Appellee filed a federal lawsuit challenging appellant Secretary's administration of Title X, which was enacted to make comprehensive voluntary family planning services readily available.

Appellate Division, First Department: March 25, 2024
Publication Date: 2024-03-25
Practice Area: Civil Appeals | Criminal Appeals
Industry:
Court: Appellate Division, First Department, Appeals & Motions
Judge: Unsigned
Attorneys:
For plaintiff:
For defendant:
Case number: DOCKET

Appeals & Motions List released on:March 21, 2024

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now